|
Abcam plc is a global biotech company based in the Cambridge Science Park in Cambridge, UK, with offices in Cambridge (Massachusetts, US), San Francisco, Hong Kong, Shanghai, and Tokyo. ==History== The idea for the company originated in the University of Cambridge laboratory, UK in 1998. The principal founder Jonathan Milner was a postdoctoral researcher studying the newly discovered breast cancer protein BRCA2 in Professor Tony Kouzarides' laboratory. The project slowed because of problems finding quality antibody reagents that had honest and up-to-date information about their uses and limitations. This scenario provided the motivation to form an on-line service that would help themselves and researchers across the globe. Since its inception in 1998, the company has diversified from carrying only antibodies. It supplies antibody related products such as immunoassays (e.g. SimpleStep ELISA Kits), peptides, proteins and protein detection products (e.g. immunohistochemistry (IHC) staining kits. Abcam also has a portfolio of non-antibody related products such as biochemicals, cellular assays, and epigenetics kits (e.g. Firefly Multiplex miRNA Kits). Abcam is a life-science e-commerce company which facilitates public customer feedback on products using reviews and ratings which customers can submit. This has given rise to the nickname "the Amazon of antibodies"〔 〕 Abcam is also listed on the London Stock Exchange. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Abcam」の詳細全文を読む スポンサード リンク
|